Akseli Hemminki

28.2k citations
348 papers · 14.9k indexed · 3 hit papers · h-index 61
Topics
Virus-based gene therapy research (217 papers)CAR-T cell therapy research (164 papers)Viral Infectious Diseases and Gene Expression in Insects (73 papers)

In The Last Decade

Akseli Hemminki

335 papers receiving 14.6k citations

Hit Papers

Incidence of Hereditary Nonpolyposis Colorectal Cancer an...1998202620072016199820162014250500750

Peers

Akseli Hemminki
Comparison fields: 5 of 142
  • Oncology 8.9k
  • Genetics 7.2k
  • Molecular Biology 6.3k
  • Pathology and Forensic Medicine 2.8k
  • Biotechnology 1.8k
Replace Nicholas R. Lemoine with:
Nicholas R. Lemoine United Kingdom
John Nemunaitis United States
Igor Puzanov United States
Stephan A. Grupp United States
Takashi Tokino Japan
Wyndham H. Wilson United States
Ignacio Melero Spain
Patrick Hwu United States
Manuel Perucho United States
Maryalice Stetler‐Stevenson United States
Akseli Hemminki relative to Nicholas R. Lemoine United Kingdom Nicholas R. Lemoine's profile →
Citations per field
00.5×3.2×
Nicholas R. Lemoine · 1×
Citations per year

Countries citing papers authored by Akseli Hemminki

Since Specialization
Citations

This map shows the geographic impact of Akseli Hemminki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akseli Hemminki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akseli Hemminki more than expected).

Fields of papers citing papers by Akseli Hemminki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akseli Hemminki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akseli Hemminki. The network helps show where Akseli Hemminki may publish in the future.

Co-authorship network of co-authors of Akseli Hemminki

This figure shows the co-authorship network connecting the top 25 collaborators of Akseli Hemminki. A scholar is included among the top collaborators of Akseli Hemminki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akseli Hemminki. Akseli Hemminki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 3
5 5
6 90
7 37
8 30
9 59
10 144
11 15
12 136
13 107
14 36
15 33
16 57
17
Treatment of cancer patients with capsid modified double controlled oncolytic adenovirus Ad5/3-Cox2L-D24
1
18 74
19 14
20
Incidence of Hereditary Nonpolyposis Colorectal Cancer and the Feasibility of Molecular Screening for the Diseasebreakdown →
856

About Akseli Hemminki

Akseli Hemminki is a scholar working on Oncology, Genetics and Biotechnology, having authored 348 papers that have together received 14.9k indexed citations. Recurring topics across this work include Virus-based gene therapy research (217 papers), CAR-T cell therapy research (164 papers) and Viral Infectious Diseases and Gene Expression in Insects (73 papers). The work is most often cited by research in Oncology (8.9k citations), Genetics (7.2k citations) and Biotechnology (1.8k citations). Akseli Hemminki has collaborated with scholars based in Finland, United States and Germany. Frequent co-authors include Kari Hemminki, Anna Kanerva, Jan Sundquist, Matias Riihimäki, Lauri A. Aaltonen, Reijo Salovaara, Vincenzo Cerullo, Kristina Sundquist, Heikki Järvinen and Otto Hemminki. Their work appears in journals such as New England Journal of Medicine, Nature Medicine and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026